News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Robert Valuck, PhD, RPH. Author Reply by Emily R. Cox, PhD

Articles by Robert Valuck, PhD, RPH. Author Reply by Emily R. Cox, PhD

Verification of a Decision Analytic Model Assumption Using Real-world Practice Data: Implications for the Cost Effectiveness of Cyclo-oxygenase 2 Inhibitors (COX-2s)

ByRobert Valuck, PhD, RPH. Author Reply by Emily R. Cox, PhD,Brenda Motheral, PhD,Doug Mager, BS

April 1st 2004

Latest Updated Articles

Verification of a Decision Analytic Model Assumption Using Real-world Practice Data: Implications for the Cost Effectiveness of Cyclo-oxygenase 2 Inhibitors (COX-2s)
Published: April 1st 2004 | Updated:

Trending on AJMC

NIH Grant Terminations Disrupt 1 in 30 Clinical Trials, Impacting Over 74,000 Participants

Rescue Therapy With Rozanolixizumab Promising in Triple-Seronegative MG

How Effective and Safe Are GLP-1s for Weight Loss?

FDA Approves Plozasiran to Reduce Triglycerides in Familial Chylomicronemia Syndrome

Nitrogen Dioxide Exposure Linked to Increased Ovarian Cancer Risk

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

© 2025 MJH Life Sciences^®

All rights reserved.